Maintenance of the PCT national phase and EP validation for the patent “combined medicinal product” (Q3929399): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: EU contribution (P835): 9,421.402 euro) |
(Changed an Item: Fixing rounding issue) |
||||||||||||||
Property / EU contribution | |||||||||||||||
9,421.40 Euro
| |||||||||||||||
Property / EU contribution: 9,421.40 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
Property / EU contribution: 9,421.40 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.00276521 Euro
| |||||||||||||||
Property / EU contribution: 9,421.40 Euro / qualifier | |||||||||||||||
point in time: 3 December 2021
|
Revision as of 00:57, 15 December 2021
Project Q3929399 in Hungary
Language | Label | Description | Also known as |
---|---|---|---|
English | Maintenance of the PCT national phase and EP validation for the patent “combined medicinal product” |
Project Q3929399 in Hungary |
Statements
3,407,120 forint
0 references
3,407,120.0 forint
0 references
100.0 percent
0 references
25 July 2015
0 references
29 June 2017
0 references
PÉCSI TUDOMÁNYEGYETEM
0 references
Pécs, Baranya
0 references
Identifiers
GINOP-2.1.3-15-2015-00029
0 references